Mirum Pharmaceuticals, Inc. , a leading rare disease company, today provided its preliminary and unaudited estimates for full-year 2025 net product sales, year-end cash balance, corporate updates and ...

The nearly 30-year tale of secalosides A and B began in 1997, when natural product chemists identified them as components of ...

A 40-year-old forgotten paper helped UChicago scientists develop a faster, more efficient method for synthesizing MXenes at a ...

The Foundation Of Advanced Materials Science Materials Shaping Modern Society It’s pretty wild when you stop and ...